The purpose of the present study is to design and synthesis of novel macrocyclic Mn2+ complex as an alternative to the well-established Gd3+ based chelates for use as an inflammation targeting MR imaging agent. This new complex exhibits higher r1 relaxivity (2.32 mM−1 s−1) than clinically approved Mn-DPDP® (1.6 mM−1 s−1) at 4.7 T. T1-weighted MR coronal images display strong signal enhancement in liver, heart, gallbladder and kidney. In an inflammatory mouse model, it shows greater inflammatory tissues detection with in a clinical dose.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords